Advertisement

Topics

Cerenis Announces the Launch of a Capital Increase for the Benefit of Persons Belonging to Specific Categories 1

15:16 EDT 13 Jun 2019 | FinanzNachrichten

Regulatory News: CERENIS Therapeutics (Paris:CEREN) (FR0012616852 CEREN PEA-PME eligible), an international biopharmaceutical company dedicated to the discovery and development of innovative thera...

Original Article: Cerenis Announces the Launch of a Capital Increase for the Benefit of Persons Belonging to Specific Categories 1

NEXT ARTICLE

More From BioPortfolio on "Cerenis Announces the Launch of a Capital Increase for the Benefit of Persons Belonging to Specific Categories 1"

Advertisement
Quick Search
Advertisement
Advertisement